Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sonia Emilia Selicean, Ciprian Tomuleasa, Ravnit Grewal, Graca Almeida-Porada & Ioana Berindan-Neagoe. (2019) Mesenchymal stem cells in myeloproliferative disorders – focus on primary myelofibrosis. Leukemia & Lymphoma 60:4, pages 876-885.
Read now
Read now
Articles from other publishers (25)
O. Yu. Vinogradova, D. I. Shikhbabaeva, Yu. N. Kobzev, A. L. Neverova, M. M. Pankraskina, S. G. Malakho, M. V. Chernikov, M. A. Murzabekova, A. G. Popova, L. B. Egoryan, A. V. Krechetova & V. V. Ptushkin. (2023) Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study. Oncohematology 18:4, pages 115-134.
Crossref
Crossref
O. Yu. Vinogradova, M. M. Pankrashkina, D. I. Shikhbabaeva, M. V. Chernikov, A. L. Neverova, V. L. Ivanova, E. A. Nikitin, E. V. Usikova & V. V. Ptushkin. (2022) Possibilities of targeted therapy for myelofibrosis: Moscow experience. Oncohematology 17:4, pages 94-105.
Crossref
Crossref
Rita Campanelli, Margherita Massa, Vittorio Rosti & Giovanni Barosi. (2021) New Markers of Disease Progression in Myelofibrosis. Cancers 13:21, pages 5324.
Crossref
Crossref
Anait Levonovna Melikyan, A.M. Kovrigina, I.N. Subortseva, V.A. Shuvaev, E.V. Morozova, E.G. Lomaia, B.V. Afanasyev, T.A. Ageeva, V.V. Baikov, O.Yu. Vinogradova, S.V. Gritsaev, A.Yu. Zaritskey, T.I. Ionova, K.D. Kaplanov, I.S. Martynkevich, T.A. Mitina, E.S. Polushkina, T.I. Pospelova, M.A. Sokolova, A.B. Sudarikov, A.G. Turkina, Yu.V. Shatokhin, R.G. Shmakov & V.G. Savchenko. (2021) National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020). Clinical oncohematology 14:2, pages 262-298.
Crossref
Crossref
Naseema Gangat & Ayalew Tefferi. (2020) Myelofibrosis biology and contemporary management. British Journal of Haematology 191:2, pages 152-170.
Crossref
Crossref
Seth J. Corey, Jyoti Jha, Elizabeth A. McCart, William B. Rittase, Jeffy George, Joseph J. Mattapallil, Hrishikesh Mehta, Mungunsukh Ognoon, Michelle A. Bylicky, Thomas A. Summers & Regina M. Day. (2018)
Captopril mitigates splenomegaly and myelofibrosis in the
Gata1
low
murine model of myelofibrosis
. Journal of Cellular and Molecular Medicine 22:9, pages 4274-4282.
Crossref
Crossref
Margaux Sevin, Lucia Kubovcakova, Nicolas Pernet, Sébastien Causse, Franck Vitte, Jean Luc Villeval, Catherine Lacout, Marine Cordonnier, Fernando Rodrigues-Lima, Gaétan Chanteloup, Matthieu Mosca, Marie-Lorraine Chrétien, Jean Noël Bastie, Sylvain Audia, Paul Sagot, Selim Ramla, Laurent Martin, Martin Gleave, Valérie Mezger, Radek Skoda, Isabelle Plo, Carmen Garrido, François Girodon & Aurélie de Thonel. (2018) HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis. Nature Communications 9:1.
Crossref
Crossref
Lanzhu Yue, Matthias Bartenstein, Wanke Zhao, Wanting Tina Ho, Ying Han, Cem Murdun, Adam W. Mailloux, Ling Zhang, Xuefeng Wang, Anjali Budhathoki, Kith Pradhan, Franck Rapaport, Huaquan Wang, Zonghong Shao, Xiubao Ren, Ulrich Steidl, Ross L. Levine, Zhizhuang Joe Zhao, Amit Verma & Pearlie K. Epling-Burnette. (2017) Efficacy of ALK5 inhibition in myelofibrosis. JCI Insight 2:7.
Crossref
Crossref
O Leiva, S K Ng, S Chitalia, A Balduini, S Matsuura & K Ravid. (2017) The role of the extracellular matrix in primary myelofibrosis. Blood Cancer Journal 7:2, pages e525-e525.
Crossref
Crossref
S Matsuura, S Patterson, H Lucero, O Leiva, A K Grant, V L M Herrera & K Ravid. (2016) In vivo magnetic resonance imaging of a mouse model of myelofibrosis. Blood Cancer Journal 6:11, pages e497-e497.
Crossref
Crossref
Adam Stelling, Brian Jonas, Hooman Rashidi, Mehrdad Abedi & Mingyi Chen. (2015) Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis. Cancers 7:4, pages 2459-2465.
Crossref
Crossref
Andrés García-García, Carlos L.F. de Castillejo & Simón Méndez-Ferrer. (2015) BMSCs and hematopoiesis. Immunology Letters 168:2, pages 129-135.
Crossref
Crossref
Edwin ChenRebekka K. SchneiderLawrence J. BreyfogleEmily A. RosenLuke PoveromoShannon ElfAmy KoKristina BrummeRoss Levine, Benjamin L. Ebert & Ann Mullally. (2015) Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms. Blood 125:2, pages 327-335.
Crossref
Crossref
Koen Schepers, Eric M. Pietras, Damien Reynaud, Johanna Flach, Mikhail Binnewies, Trit Garg, Amy J. Wagers, Edward C. Hsiao & Emmanuelle Passegué. (2013) Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche. Cell Stem Cell 13:3, pages 285-299.
Crossref
Crossref
Maria Zingariello, Fabrizio MartelliFiorella CiaffoniFrancesca MasielloBarbara GhinassiEmanuela D’AmoreMargherita MassaGiovanni BarosiLaura Sancillo, Xiaochun Li, Judith D. Goldberg, Rosa Alba Rana & Anna Rita Migliaccio. (2013) Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood 121:17, pages 3345-3363.
Crossref
Crossref
Daniel Lucas, Sandra Pinho & Paul S. Frenette. 2013. Mesenchymal Stromal Cells. Mesenchymal Stromal Cells
91
106
.
Alexandra MazharianYing-Jie WangJun MoriDanai BemBrenda FinneySilke HeisingPaul GissenJames G. WhiteMichael C. BerndtElizabeth E. GardinerBernhard NieswandtMichael R. DouglasRobert D. CampbellSteve P. WatsonYotis A. Senis. (2012) Mice Lacking the ITIM-Containing Receptor G6b-B Exhibit Macrothrombocytopenia and Aberrant Platelet Function. Science Signaling 5:248.
Crossref
Crossref
Claudio TripodoSabina SangalettiCarla GuarnottaPier P. PiccalugaMatilde CacciatoreMichela GiulianoGiovanni FrancoClaudia ChiodoniMarika SciandraSilvia MiottiGiuseppe CalvarusoAlessandra Carè, Ada M. FlorenaKatia ScotlandiAttilio Orazi, Stefano A. PileriMario P. Colombo. (2012) Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. Blood 120:17, pages 3541-3554.
Crossref
Crossref
Koen SchepersEdward C. Hsiao, Trit GargMark J. Scott & Emmanuelle Passegué. (2012) Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice. Blood 120:17, pages 3425-3435.
Crossref
Crossref
Nikolaos Papadantonakis, Shinobu Matsuura & Katya Ravid. (2012) Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection. Blood 120:9, pages 1774-1781.
Crossref
Crossref
Ann MullallyLuke PoveromoRebekka K. SchneiderFatima Al-Shahrour, Steven W. Lane & Benjamin L. Ebert. (2012) Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera. Blood 120:1, pages 166-172.
Crossref
Crossref
Geneviève Despars & Yves St-Pierre. (2011) Bidirectional interactions between bone metabolism and hematopoiesis. Experimental Hematology 39:8, pages 809-816.
Crossref
Crossref
Carlos E. Bueso-Ramos & James W. Vardiman. 2011. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms
1
37
.
Maria Verrucci, Alessandro Pancrazzi, Miguel Aracil, Fabrizio Martelli, Paola Guglielmelli, Maria Zingariello, Barbara Ghinassi, Emanuela D'Amore, José Jimeno, Alessandro M. Vannucchi & Anna Rita Migliaccio. (2010)
CXCR4‐independent rescue of the myeloproliferative defect of the gata1
low
myelofibrosis mouse model by Aplidin®
. Journal of Cellular Physiology 225:2, pages 490-499.
Crossref
Crossref
Gergely T. Kozma, Fabrizio Martelli, Maria Verrucci, Laura Gutiérrez, Giovanni Migliaccio, Massimo Sanchez, Elena Alfani, Sjaak Philipsen & Anna Rita Migliaccio. (2010) Dynamic regulation of Gata1 expression during the maturation of conventional dendritic cells. Experimental Hematology 38:6, pages 489-503.e1.
Crossref
Crossref